Cott (TSE:PRM) Upgraded to “Strong-Buy” at William Blair

William Blair upgraded shares of Cott (TSE:PRM) to a strong-buy rating in a report published on Thursday, Zacks.com reports.

Separately, Raymond James cut Cott from a “moderate buy” rating to a “hold” rating in a research report on Wednesday, October 2nd.

Cott Stock Up 0.1 %

Shares of TSE:PRM opened at C$13.77 on Thursday. Cott has a 12-month low of C$13.20 and a 12-month high of C$14.97.

Cott (TSE:PRM) last announced its quarterly earnings data on Thursday, August 8th. The company reported C$0.30 EPS for the quarter, missing the consensus estimate of C$0.32 by C($0.02). The company had revenue of C$663.59 million for the quarter, compared to the consensus estimate of C$658.00 million.

Cott Dividend Announcement

The firm also recently disclosed a None dividend, which will be paid on Thursday, November 21st. Investors of record on Tuesday, November 5th will be issued a $1.109 dividend. The ex-dividend date of this dividend is Tuesday, November 5th.

About Cott

Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.